Race and Equity

Aducanumab is the first new drug approved to treat Alzheimer’s disease in nearly 20 years. But some in the medical community were stunned by the approval.

Race and Equity, Poverty and Class, Environmental Health, Healthcare Regulation and Reform, Mental Health, Chronic Disease

This story was written by SweSwe Aye while participating in the USC Annenberg Center for Health Journalism's 2021 California Fellowship.

Race and Equity, Poverty and Class, Environmental Health, Healthcare Regulation and Reform

Dana Ullman is reporting on health-related stories for The Mendocino Voice with support from the USC Annenberg Center for Health Journalism. This article was produced as a series for the 2021 Center for Health Journalism California Fellowship.

Race and Equity, Environmental Health, Poverty and Class, Healthcare Regulation and Reform

African American are resilient, but enough is enough, says Observer senior staff writer.

Race and Equity, Environmental Health, Poverty and Class, Healthcare Regulation and Reform, Community Safety